Biological determinants of cancer progression in men with prostate cancer.

CONTEXT The recent increase in ability to diagnose prostatic adenocarcinoma has created a dilemma for treatment decisions. OBJECTIVE To determine whether prostate cancer progression is associated with a modified version of the Gleason grading system together with selected morphologic and clinical variables. DESIGN Retrospective analysis of a cohort of patients with peripheral zone prostate cancers who underwent surgery between August 1983 and July 1992. SETTING University hospital. PATIENTS Radical prostatectomy specimens from 379 men treated only by surgical excision were prospectively studied for 8 morphologic variables using previously standardized techniques. Variables were percentage of each cancer occupied by Gleason grade 4/5 (% Gleason grade 4/5, the Stanford modified Gleason scale), cancer volume, vascular invasion, lymph node involvement, seminal vesicle invasion, capsular penetration, positive surgical margin, prostate weight, and preoperative prostate-specific antigen (PSA) level. MAIN OUTCOME MEASURE Biochemical progression of prostate cancer as indicated by serum PSA level of 0.07 ng/mL and increasing. RESULTS Cancer grade expressed as % Gleason grade 4/5 and cancer volume were highly predictive of disease progression. In a Cox proportional hazards model that included % Gleason grade 4/5, the traditional Gleason score was not an independent predictor of treatment failure. Positive lymph node findings and intraprostatic vascular invasion were the only other variables that remained significant at the .01 level. CONCLUSION The % Gleason grade 4/5, cancer volume, positive lymph node findings, and intraprostatic vascular invasion were independently associated with prostate cancer progression, defined by an increasing PSA level. Techniques to accurately measure cancer volume and % Gleason grade 4/5 are needed to better predict which patient will experience cancer progression. The commonly accepted predictors of progression-capsular penetration and positive surgical margins-were not independently predictive of failure after radical prostatectomy.

[1]  T. Stamey,et al.  Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: common ground for therapeutic trials and TNM subgroups. , 1998, The Journal of urology.

[2]  J. Isaacs Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. , 1997, The American journal of pathology.

[3]  B. Ripley,et al.  Modern Applied Statistics with S-Plus. , 1996 .

[4]  J. McNeal,et al.  Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. , 1996, The American journal of surgical pathology.

[5]  J. McNeal,et al.  Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. , 1996, The American journal of surgical pathology.

[6]  T. Stamey Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians. , 1996, Clinical chemistry.

[7]  P. Troncoso,et al.  Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. , 1995, The Journal of urology.

[8]  T. Stamey,et al.  A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. , 1994, The Journal of urology.

[9]  T. Stamey,et al.  Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors , 1992, Cancer.

[10]  D. Cox,et al.  Analysis of Binary Data (2nd ed.). , 1990 .

[11]  T. Stamey,et al.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.

[12]  T. Stamey,et al.  Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment , 1990, The American journal of surgical pathology.

[13]  F. Mosteller,et al.  Data Analysis and Regression , 1978 .

[14]  D. Cox,et al.  The analysis of binary data , 1971 .

[15]  T. Stamey,et al.  Making the most out of six systematic sextant biopsies. , 1995, Urology.

[16]  Gleason Df,et al.  [Gleason's classification of prostatic adenocarcinomas]. , 1991 .